Medpace Holdings, Inc. (MEDP) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in Cincinnati, OH, United States. The current CEO is August James Troendle.
MEDP has IPO date of 2016-08-11, 5,900 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $14.85B.
Medpace Holdings, Inc. is a clinical research organization that provides comprehensive drug and medical device development services to pharmaceutical, biotechnology, and medical device companies across North America, Europe, and Asia. The company supports the entire clinical development lifecycle from Phase I through Phase IV trials, offering specialized services including clinical monitoring, regulatory affairs, data management, pharmacovigilance, and post-marketing support across multiple therapeutic areas. Medpace also provides specialized laboratory services including bio-analytical testing, clinical human pharmacology, imaging services, and electrocardiography support. Founded in 1992 and headquartered in Cincinnati, Ohio, the company serves as a trusted partner in advancing new drug and device candidates toward regulatory approval.
